Literature DB >> 7713787

The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy.

L B Marks1, P R Carroll, T C Dugan, M S Anscher.   

Abstract

A comprehensive review of the physiological and clinical response of the urinary bladder, ureter, and urethra to radiation and chemotherapy is presented. The clinical syndromes that follow therapy for cancer of the bladder, prostate, and cervix are reviewed in detail. Methods of assessing, scoring, and managing toxicity are discussed.

Entities:  

Mesh：

Year:  1995        PMID： 7713787     DOI： 10.1016/0360-3016(94)00431-J

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  79 in total

Review 1.  Treating cancer patients. Practical monitoring and management of therapy-related complications.

Authors:  M Brigden; M McKenzie
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

2.  Effects of tamoxifen on Doppler velocimetry parameters of periurethral vessels in postmenopausal women.

Authors:  Carlos A Faria; Marair G F Sartori; Edmund C Baracat; Geraldo Rodrigues de Lima; Manoel J B C Girão
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-08-25

Review 3.  Radiation dose-volume effects of the urinary bladder.

Authors:  Akila N Viswanathan; Ellen D Yorke; Lawrence B Marks; Patricia J Eifel; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

4.  On the impact of functional imaging accuracy on selective boosting IMRT.

Authors:  Y Kim; W A Tomé
Journal:  Phys Med       Date:  2008-01-18       Impact factor: 2.685

5.  Lower urinary tract dysfunction and quality of life in cervical cancer survivors after concurrent chemoradiation versus radical hysterectomy.

Authors:  Chanita Katepratoom; Tarinee Manchana; Napapat Amornwichet
Journal:  Int Urogynecol J       Date:  2013-07-02       Impact factor: 2.894

6.  Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans.

Authors:  Yusung Kim; Wolfgang A Tome
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

7.  Observations and outcomes of urethroplasty for bulbomembranous stenosis after radiation therapy for prostate cancer.

Authors:  Keith Rourke; Adam Kinnaird; Jeff Zorn
Journal:  World J Urol       Date:  2015-06-06       Impact factor: 4.226

8.  Intravesical instillations with polydeoxyribonucleotides reduce symptoms of radiation-induced cystitis in patients treated with radiotherapy for pelvic cancer: a pilot study.

Authors:  Pierluigi Bonfili; Pietro Franzese; Francesco Marampon; Maria Emilia La Verghetta; Silvia Parente; Manuela Cerasani; Daniela Di Genova; Marta Mancini; Francesca Vittorini; Giovanni Luca Gravina; Valeria Ruggieri; Mario Di Staso; Vladimir M Popov; Vincenzo Tombolini; Ernesto Di Cesare
Journal:  Support Care Cancer       Date:  2013-12-10       Impact factor: 3.603

Review 9.  Radiation-induced fibrosis: mechanisms and implications for therapy.

Authors:  Jeffrey M Straub; Jacob New; Chase D Hamilton; Chris Lominska; Yelizaveta Shnayder; Sufi M Thomas
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-25       Impact factor: 4.553

10.  Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation.

Authors:  Katrien Vandecasteele; Wilfried De Neve; Werner De Gersem; Louke Delrue; Leen Paelinck; Amin Makar; Valérie Fonteyne; Carlos De Wagter; Geert Villeirs; Gert De Meerleer
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.